Literature DB >> 6603688

A function for human T200 in natural killer cytolysis.

R L Sparrow, I F McKenzie.   

Abstract

The ability of an antihuman T200 monoclonal antibody, F2.5, to specifically inhibit in vitro human natural killer cell-mediated lysis of K562 target cells is demonstrated. No inhibition by the F2.5 antibody of a cytotoxic T lymphocyte response to autologous virus-infected cells could be shown. Direct binding studies indicated that F2.5 antibody-coated effector cells had a reduced capacity to bind to K562 target cells, suggesting that T200 has a function in the recognition and binding of the natural killer cell to its target cell. This is the first time a role for human T200 and identification of a functional natural killer cell receptor have been described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603688     DOI: 10.1097/00007890-198308000-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  The isolation of cDNA clones for CD48.

Authors:  H A Vaughan; M M Henning; D F Purcell; I F McKenzie; M S Sandrin
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.

Authors:  T C Prickett; D N Hart
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

Review 3.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

4.  Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.

Authors:  G C Starling; S E Davidson; J L McKenzie; D N Hart
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

5.  Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.

Authors:  G C Starling; S E Davidson; J C Nimmo; M E Beard; D N Hart
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.

Authors:  G C Starling; D N Hart
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

7.  The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45.

Authors:  L A Terry; M H Brown; P C Beverley
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

8.  Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase.

Authors:  S Volarević; C M Burns; J J Sussman; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  The extra segments of sequence in rat leucocyte common antigen (L-CA) are derived by alternative splicing of only three exons and show extensive O-linked glycosylation.

Authors:  D I Jackson; A N Barclay
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

10.  The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens.

Authors:  C E Rudd; C Morimoto; L L Wong; S F Schlossman
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.